ThreeD Capital Inc
CNSX:IDK
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
T
|
ThreeD Capital Inc
CNSX:IDK
|
CA |
|
Global Pharmatech Inc
OTC:GBLP
|
CN |
Balance Sheet
Balance Sheet Decomposition
ThreeD Capital Inc
ThreeD Capital Inc
Balance Sheet
ThreeD Capital Inc
| Jun-2002 | Jun-2003 | Jun-2004 | Jun-2005 | Jun-2006 | Jun-2007 | Jun-2008 | Jun-2009 | Jun-2010 | Jun-2011 | Jun-2012 | Jun-2013 | Jun-2014 | Jun-2015 | Jun-2016 | Jun-2017 | Jun-2018 | Jun-2019 | Jun-2020 | Jun-2021 | Jun-2022 | Jun-2023 | Jun-2024 | Jun-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||||||||||||||
| Cash & Cash Equivalents |
0
|
0
|
0
|
0
|
3
|
36
|
11
|
2
|
2
|
30
|
18
|
10
|
5
|
3
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Cash |
0
|
0
|
0
|
0
|
3
|
36
|
11
|
2
|
2
|
0
|
0
|
0
|
0
|
3
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Cash Equivalents |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
30
|
18
|
10
|
5
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Short-Term Investments |
0
|
0
|
0
|
6
|
23
|
25
|
57
|
19
|
17
|
12
|
3
|
2
|
4
|
5
|
2
|
8
|
21
|
21
|
0
|
0
|
1
|
4
|
0
|
0
|
|
| Total Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
4
|
5
|
3
|
1
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
|
| Other Current Assets |
0
|
0
|
0
|
1
|
0
|
0
|
0
|
1
|
0
|
5
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
1
|
1
|
|
| Total Current Assets |
0
|
0
|
0
|
7
|
26
|
61
|
73
|
27
|
23
|
48
|
22
|
13
|
10
|
9
|
2
|
8
|
21
|
22
|
1
|
1
|
1
|
0
|
1
|
2
|
|
| PP&E Net |
1
|
0
|
0
|
0
|
0
|
16
|
31
|
38
|
36
|
42
|
45
|
17
|
5
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| PP&E Gross |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
|
| Note Receivable |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Long-Term Investments |
2
|
2
|
3
|
0
|
8
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
14
|
55
|
50
|
40
|
55
|
29
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
1
|
2
|
1
|
5
|
5
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Assets |
3
N/A
|
3
-19%
|
3
+15%
|
7
+120%
|
34
+417%
|
79
+133%
|
104
+31%
|
71
-32%
|
64
-9%
|
91
+42%
|
68
-25%
|
30
-55%
|
15
-50%
|
9
-42%
|
2
-76%
|
8
+287%
|
21
+164%
|
22
+5%
|
15
-32%
|
57
+279%
|
51
-9%
|
40
-22%
|
56
+39%
|
31
-44%
|
|
| Liabilities | |||||||||||||||||||||||||
| Accounts Payable |
2
|
2
|
1
|
1
|
0
|
1
|
1
|
0
|
2
|
2
|
1
|
3
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
1
|
0
|
1
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
0
|
0
|
0
|
0
|
0
|
3
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
1
|
0
|
1
|
0
|
0
|
0
|
11
|
0
|
|
| Total Current Liabilities |
2
|
3
|
1
|
1
|
0
|
4
|
3
|
0
|
2
|
2
|
1
|
4
|
1
|
0
|
1
|
0
|
1
|
0
|
2
|
2
|
1
|
1
|
11
|
1
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
|
| Deferred Income Tax |
0
|
0
|
0
|
0
|
3
|
0
|
3
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Liabilities |
2
N/A
|
3
+23%
|
1
-52%
|
1
-54%
|
3
+400%
|
4
+27%
|
6
+58%
|
0
-93%
|
2
+425%
|
2
-29%
|
1
-23%
|
4
+209%
|
1
-71%
|
0
-76%
|
1
+263%
|
0
-80%
|
1
+413%
|
1
-42%
|
2
+228%
|
3
+62%
|
1
-79%
|
1
+16%
|
11
+1 629%
|
1
-91%
|
|
| Equity | |||||||||||||||||||||||||
| Common Stock |
7
|
7
|
7
|
7
|
18
|
50
|
49
|
55
|
65
|
97
|
97
|
97
|
97
|
97
|
97
|
99
|
107
|
109
|
111
|
115
|
111
|
110
|
109
|
109
|
|
| Retained Earnings |
6
|
7
|
6
|
1
|
12
|
22
|
45
|
3
|
16
|
26
|
53
|
94
|
107
|
113
|
121
|
117
|
114
|
116
|
126
|
94
|
98
|
111
|
108
|
125
|
|
| Additional Paid In Capital |
0
|
0
|
0
|
0
|
1
|
3
|
5
|
12
|
13
|
22
|
24
|
24
|
25
|
25
|
25
|
25
|
27
|
28
|
28
|
32
|
37
|
39
|
43
|
45
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
3
|
1
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
|
| Total Equity |
1
N/A
|
0
N/A
|
2
N/A
|
6
+275%
|
31
+418%
|
76
+143%
|
99
+30%
|
70
-29%
|
62
-12%
|
89
+44%
|
67
-25%
|
27
-60%
|
14
-48%
|
8
-40%
|
1
-86%
|
8
+568%
|
20
+159%
|
22
+7%
|
13
-39%
|
54
+307%
|
51
-5%
|
40
-22%
|
45
+13%
|
30
-32%
|
|
| Total Liabilities & Equity |
3
N/A
|
3
-19%
|
3
+15%
|
7
+120%
|
34
+417%
|
79
+133%
|
104
+31%
|
71
-32%
|
64
-9%
|
91
+42%
|
68
-25%
|
30
-55%
|
15
-50%
|
9
-42%
|
2
-76%
|
8
+287%
|
21
+164%
|
22
+5%
|
15
-32%
|
57
+279%
|
51
-9%
|
40
-22%
|
56
+39%
|
31
-44%
|
|
| Shares Outstanding | |||||||||||||||||||||||||
| Common Shares Outstanding |
1
|
1
|
1
|
1
|
1
|
2
|
2
|
2
|
3
|
130
|
130
|
130
|
130
|
1
|
1
|
4
|
10
|
16
|
32
|
46
|
48
|
50
|
52
|
77
|
|